TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 13, 2009, Pages 5306-5311

  Aldridge, Jerry R ^a   Moseley, Carson E ^a   Boltz, David A ^a   Negovetich, Nicholas J ^a   Reynolds, Cory ^b   Franks, John ^a   Brown, Scott A ^b   Doherty, Peter C ^b   Webster, Robert G ^a   Thomas, Paul G ^b  

^a Division of Virology

^b ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

H5N1; Inflammation; Pathogenesis

Indexed keywords

CHEMOKINE RECEPTOR CCR2; INDUCIBLE NITRIC OXIDE SYNTHASE; PIOGLITAZONE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL EXPANSION; CELL MIGRATION; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFECT; INFLUENZA; INFLUENZA VIRUS A H5N1; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS STRAIN;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; CELL PROLIFERATION; DENDRITIC CELLS; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; LUNG DISEASES; MICE; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE II; ORTHOMYXOVIRIDAE INFECTIONS; RECEPTORS, CCR2; TUMOR NECROSIS FACTOR-ALPHA;

INFLUENZA A VIRUS; MUS; ORTHOMYXOVIRIDAE;

EID: 65249145291     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0900655106     Document Type: Article

References (29)

1. Meltzer Ml, CoxNJ, Fukuda K (1999) The economic impact of pandemic influenza in the United States: Priorities for intervention. Emerg Infect Dis 5:659-671.
2. HorimotoT, Kawaoka Y (2005) Influenza: Lessons from past pandemics, warnings from current incidents. Nat Rev Microbiol 3:591-600.
3. Loo YM, Gale M, Jr (2007) Influenza: Fatal immunity and the 1918 virus. Nature 445:267-268.
4. Palese P (2004) Influenza: Old and new threats. Nat Med 10:S82-S87.
5. Smith K (2007) Concern as revived 1918 flu virus kills monkeys. Nature 445:237.
6. Taubenberger JK, et al. (2005) Characterization of the 1918 influenza virus polymerase genes. Nature 437:889-893.
7. Tumpey TM, et al. (2005) Characterization of the reconstructed 1918 Spanish influenza pandemic virus. Science 310:77-80.
8. Taubenberger JK, Morens DM (2006) 1918 Influenza: The mother of all pandemics. Emerg Infect Dis 12:15-22.
9. World Health Organization (2009) Cumulative number of confirmed human cases of avian influenza A/(H5N1) reported to WHO (World Health Organization, Geneva, Switzerland). Available at www.who.int/csr/disease/avian-influenza/ country/cases-table-2009-01-22/en/index.html. Accessed January 23, 2009.
10. Kash JC, et al. (2006) Genomic analysis of increased host immune and cell death responses induced by 1918 influenza virus. Nature 443:578-581.
11. Kobasa D, et al. (2007) Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature 445:319-323.
12. Kobasa D, et al. (2004) Enhanced virulence of influenza A viruses with the haemagglutinin of the 1918 pandemic virus. Nature 431:703-707.
13. Chan MC, et al. (2005) Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res 6:135.
14. Cheung CY, et al. (2002) Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: A mechanism for the unusual severity of human disease? Lancet 360:1831-1837.
15. Serbina NV, et al. (2003) TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity 19:59-70.
16. Serbina NV, Pamer EG (2006) Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 7:311-317.
17. Dawson TC, et al. (2000) Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. Am J Pathol 156:1951-1959.
18. + monocyte-derived dendritic cells and exudate macrophages produce influenza-induced pulmonary immune pathology and mortality. J Immunol 180:2562-2572.
19. + T-cell mechanisms in the control of respiratory virus infections. Immunol Rev 159:105-117.
20. + T cells clear influenza virus by perforin or Fas-dependent processes. J Immunol 159:5197-5200.
21. + T cell response. Proc Natl Acad Sci USA 100:7235-7240.
22. McGill J, Van Rooijen N, Legge KL (2008) Protective influenza-specific CD8T cell responses require interactions with dendritic cells in the lungs. J Exp Med 205:1635-1646.
23. Di Gregorio GB, et al. (2005) Expression of CD68 and macrophage chemoattractant protein-1 genes in human adipose and muscle tissues: Association with cytokine expression, insulin resistance, and reduction by pioglitazone. Diabetes 54:2305-2313.
24. Haraguchi G, et al. (2008) Pioglitazone reduces systematic inflammation and improves mortality in apolipoprotein E knockout mice with sepsis. Intensive Care Med 34:1304-1312.
25. Ito H, Nakano A, Kinoshita M, Matsumori A (2003) Pioglitazone, a peroxisome proliferator-activated receptor-γ agonist, attenuates myocardial ischemia/reperfusion injury in a rat model. Lab Invest 83:1715-1721.
26. Herold S, et al. (2008) Lung epithelial apoptosis in influenza virus pneumonia: The role of macrophage-expressed TNF-related apoptosis-inducing ligand. J Exp Med 205:3065-3077.
27. Salomon R, Hoffmann E, Webster RG (2007) Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc Natl Acad Sci USA 104:12479-12481.
28. Lowes MA, et al. (2005) Increase in TNF-αand inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD 11a). Proc Natl Acad Sci USA 102:19057-19062.
29. Hoffmann E, et al. (2000) A DNAtransfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci USA 97:6108-6113.